Efficacy of rivaroxaban in prevention of post-thrombotic syndrome: a systematic review and meta-analysis

C Karathanos, P Nana, K Spanos, G Kouvelos… - Journal of Vascular …, 2021 - Elsevier
Abstract Objective Direct oral anticoagulants (DOACs) have been recommended for the
treatment of deep vein thrombosis (DVT). However, the benefits are uncertain for the …
被引用次数：21 相关文章

Efficacy of rivaroxaban in prevention of post-thrombotic syndrome: A systematic review and meta-analysis

C Karathanos, P Nana, K Spanos… - Journal of vascular …, 2021 - pubmed.ncbi.nlm.nih.gov
Objective Direct oral anticoagulants (DOACs) have been recommended for the treatment of
deep vein thrombosis (DVT). However, the benefits are uncertain for the prevention of post …

Efficacy of rivaroxaban in prevention of post-thrombotic syndrome: A systematic review and meta-analysis

C Karathanos, P Nana, K Spanos, G Kouvelos, A Brotis… - 2021 - ir.lib.uth.gr
Objective: Direct oral anticoagulants (DOACs) have been recommended for the treatment of
deep vein thrombosis (DVT). However, the benefits are uncertain for the prevention of post …

Efficacy of rivaroxaban in prevention of post-thrombotic syndrome: A systematic review and meta-analysis

C Karathanos, P Nana, K Spanos… - Journal of Vascular …, 2021 - jvsvenous.org
Abstract Objective Direct oral anticoagulants (DOACs) have been recommended for the
treatment of deep vein thrombosis (DVT). However, the benefits are uncertain for the …

Efficacy of rivaroxaban in prevention of post-thrombotic syndrome: A systematic review and meta-analysis.

C Karathanos, P Nana, K Spanos… - Journal of Vascular …, 2021 - europepmc.org
Objective Direct oral anticoagulants (DOACs) have been recommended for the treatment of
deep vein thrombosis (DVT). However, the benefits are uncertain for the prevention of post …